Hyperpituitarism

Revision as of 14:39, 20 September 2012 by Charmaine Patel (talk | contribs)
Jump to navigation Jump to search

For patient information click here

Hyperpituitarism
ICD-10 E22
ICD-9 253.1
MeSH D006964

Hyperpituitarism Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hyperpituitarism from other Diseases

Epidemiology and Demographics

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hyperpituitarism On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hyperpituitarism

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hyperpituitarism

CDC on Hyperpituitarism

Hyperpituitarism in the news

Blogs on Hyperpituitarism

Directions to Hospitals Treating Hyperpituitarism

Risk calculators and risk factors for Hyperpituitarism

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Clinical manifestations

Depending on the cell type(s) affected, clinical manifestations of hormone excess may include:

Associated conditions

When there is an enlargement of the pituitary tissue, hyperpituitarism is often associated with:

Symptoms

Symptoms caused by hormone excess and associated mass effects include:



Template:WikiDoc Sources